Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery

Plant-associated endophytes define an important symbiotic association in nature and are established bio-reservoirs of plant-derived natural products. Endophytes colonize the internal tissues of a plant without causing any disease symptoms or apparent changes. Recently, there has been a growing inter...

Full description

Bibliographic Details
Main Authors: Pragya Tiwari, Hanhong Bae
Format: Article
Language:English
Published: MDPI AG 2022-02-01
Series:Microorganisms
Subjects:
Online Access:https://www.mdpi.com/2076-2607/10/2/360
_version_ 1827653678124761088
author Pragya Tiwari
Hanhong Bae
author_facet Pragya Tiwari
Hanhong Bae
author_sort Pragya Tiwari
collection DOAJ
description Plant-associated endophytes define an important symbiotic association in nature and are established bio-reservoirs of plant-derived natural products. Endophytes colonize the internal tissues of a plant without causing any disease symptoms or apparent changes. Recently, there has been a growing interest in endophytes because of their beneficial effects on the production of novel metabolites of pharmacological significance. Studies have highlighted the socio-economic implications of endophytic fungi in agriculture, medicine, and the environment, with considerable success. Endophytic fungi-mediated biosynthesis of well-known metabolites includes taxol from <i>Taxomyces andreanae</i>, azadirachtin A and B from <i>Eupenicillium parvum</i>, vincristine from <i>Fusarium oxysporum</i>, and quinine from <i>Phomopsis</i> sp. The discovery of the billion-dollar anticancer drug taxol was a landmark in endophyte biology/research and established new paradigms for the metabolic potential of plant-associated endophytes. In addition, endophytic fungi have emerged as potential prolific producers of antimicrobials, antiseptics, and antibiotics of plant origin. Although extensively studied as a “production platform” of novel pharmacological metabolites, the molecular mechanisms of plant–endophyte dynamics remain less understood/explored for their efficient utilization in drug discovery. The emerging trends in endophytic fungi-mediated biosynthesis of novel bioactive metabolites, success stories of key pharmacological metabolites, strategies to overcome the existing challenges in endophyte biology, and future direction in endophytic fungi-based drug discovery forms the underlying theme of this article.
first_indexed 2024-03-09T21:24:06Z
format Article
id doaj.art-cd6739810173429b91517f17dc10e464
institution Directory Open Access Journal
issn 2076-2607
language English
last_indexed 2024-03-09T21:24:06Z
publishDate 2022-02-01
publisher MDPI AG
record_format Article
series Microorganisms
spelling doaj.art-cd6739810173429b91517f17dc10e4642023-11-23T21:14:53ZengMDPI AGMicroorganisms2076-26072022-02-0110236010.3390/microorganisms10020360Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug DiscoveryPragya Tiwari0Hanhong Bae1Molecular Metabolic Engineering Lab, Department of Biotechnology, Yeungnam University, Gyeongsan 38541, KoreaMolecular Metabolic Engineering Lab, Department of Biotechnology, Yeungnam University, Gyeongsan 38541, KoreaPlant-associated endophytes define an important symbiotic association in nature and are established bio-reservoirs of plant-derived natural products. Endophytes colonize the internal tissues of a plant without causing any disease symptoms or apparent changes. Recently, there has been a growing interest in endophytes because of their beneficial effects on the production of novel metabolites of pharmacological significance. Studies have highlighted the socio-economic implications of endophytic fungi in agriculture, medicine, and the environment, with considerable success. Endophytic fungi-mediated biosynthesis of well-known metabolites includes taxol from <i>Taxomyces andreanae</i>, azadirachtin A and B from <i>Eupenicillium parvum</i>, vincristine from <i>Fusarium oxysporum</i>, and quinine from <i>Phomopsis</i> sp. The discovery of the billion-dollar anticancer drug taxol was a landmark in endophyte biology/research and established new paradigms for the metabolic potential of plant-associated endophytes. In addition, endophytic fungi have emerged as potential prolific producers of antimicrobials, antiseptics, and antibiotics of plant origin. Although extensively studied as a “production platform” of novel pharmacological metabolites, the molecular mechanisms of plant–endophyte dynamics remain less understood/explored for their efficient utilization in drug discovery. The emerging trends in endophytic fungi-mediated biosynthesis of novel bioactive metabolites, success stories of key pharmacological metabolites, strategies to overcome the existing challenges in endophyte biology, and future direction in endophytic fungi-based drug discovery forms the underlying theme of this article.https://www.mdpi.com/2076-2607/10/2/360anti-infectivesbioactive metabolitesbiosynthetic gene clusters (BCG)drug discoveryendophytic fungifungal pharmacology
spellingShingle Pragya Tiwari
Hanhong Bae
Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery
Microorganisms
anti-infectives
bioactive metabolites
biosynthetic gene clusters (BCG)
drug discovery
endophytic fungi
fungal pharmacology
title Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery
title_full Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery
title_fullStr Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery
title_full_unstemmed Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery
title_short Endophytic Fungi: Key Insights, Emerging Prospects, and Challenges in Natural Product Drug Discovery
title_sort endophytic fungi key insights emerging prospects and challenges in natural product drug discovery
topic anti-infectives
bioactive metabolites
biosynthetic gene clusters (BCG)
drug discovery
endophytic fungi
fungal pharmacology
url https://www.mdpi.com/2076-2607/10/2/360
work_keys_str_mv AT pragyatiwari endophyticfungikeyinsightsemergingprospectsandchallengesinnaturalproductdrugdiscovery
AT hanhongbae endophyticfungikeyinsightsemergingprospectsandchallengesinnaturalproductdrugdiscovery